19-36142713-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001749.4(CAPNS1):c.305G>A(p.Arg102Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000111 in 1,613,940 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R102W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001749.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CAPNS1 | NM_001749.4 | c.305G>A | p.Arg102Gln | missense_variant | 4/11 | ENST00000246533.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CAPNS1 | ENST00000246533.8 | c.305G>A | p.Arg102Gln | missense_variant | 4/11 | 1 | NM_001749.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152082Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251324Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135826
GnomAD4 exome AF: 0.000109 AC: 159AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 78AN XY: 727236
GnomAD4 genome AF: 0.000132 AC: 20AN: 152082Hom.: 1 Cov.: 31 AF XY: 0.000162 AC XY: 12AN XY: 74272
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.305G>A (p.R102Q) alteration is located in exon 4 (coding exon 3) of the CAPNS1 gene. This alteration results from a G to A substitution at nucleotide position 305, causing the arginine (R) at amino acid position 102 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at